MedTrace Logo

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

NCT00187577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2011-06-09

No results posted yet for this study

Summary

This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.

Conditions

Interventions

DRUG

Latanoprost (Xalatan)

DRUG

Bimatoprost (Lumigan)

Bimatoprost solution will be applied to affected eyelid(s) with cotton-tipped applicator daily.

DRUG

Topical application of latanoprost solution to eyelid

Subject will apply latanoprost to affected eyelid with cotton-tipped applicator daily.

Sponsors & Collaborators

Principal Investigators

  • Vera H. Price, M.D. · Professor, University of California, San Francisco Department of Dermatology

  • Robert L. Stamper, M.D. · Professor, University of California, San Francisco Department of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2006-02-28
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00187577 on ClinicalTrials.gov